Results for tag: "Folotyn"

Folotyn (pralatrexate) is a drug used to treat peripheral T-cell lymphoma (PTCL). It is a type of chemotherapy drug that works by blocking the growth of cancer cells. It is administered intravenously and is approved for use in adults. Folotyn is marketed by Spectrum Pharmaceuticals, Inc. in the United States and by Mundipharma International Corporation Limited in Europe. It is also available in other countries through various distributors. The Folotyn market is a rapidly growing segment of the lymphoma drugs market. It is expected to grow due to increasing prevalence of PTCL and increasing awareness of the drug. The drug is also expected to benefit from the increasing number of clinical trials and research studies being conducted. Companies in the Folotyn market include Spectrum Pharmaceuticals, Inc., Mundipharma International Corporation Limited, and various distributors. Show Less Read more